OLOPATADINE HYDROCHLORIDE

OLOPATADINE HYDROCHLORIDE was reported 5840 times

These side effects are most commonly reported by patients taking OLOPATADINE HYDROCHLORIDE:

# Side effect Count
0 TREATMENT FAILURE 1943
1 DRUG INEFFECTIVE 600
2 EYE IRRITATION 314
3 VISION BLURRED 232
4 EYE PAIN 189
5 HEADACHE 187
6 EYE DISCHARGE 178
7 OCULAR HYPERAEMIA 157
8 EYE PRURITUS 156
9 NAUSEA 150
10 DIARRHOEA 134
11 FATIGUE 130
12 RASH 129
13 PRURITUS 124
14 PYREXIA 121
15 CONDITION AGGRAVATED 119
16 MALAISE 116
17 DYSPNOEA 115
18 PNEUMONIA 115
19 COUGH 114
20 DIZZINESS 114
21 HYPERSENSITIVITY 112
22 PAIN 107
23 OFF LABEL USE 106
24 PRODUCT DOSE OMISSION ISSUE 99
25 SINUSITIS 98
26 ARTHRALGIA 92
27 DRY EYE 84
28 VOMITING 82
29 EYE SWELLING 78
30 OCULAR DISCOMFORT 76
31 ASTHMA 72
32 DECREASED APPETITE 72
33 NASOPHARYNGITIS 72
34 LACRIMATION INCREASED 71
35 WEIGHT INCREASED 68
36 ERYTHEMA 63
37 FALL 62
38 URINARY TRACT INFECTION 61
39 BRONCHITIS 60
40 WEIGHT DECREASED 60
41 INSOMNIA 59
42 COVID-19 57
43 ANAEMIA 56
44 DRUG HYPERSENSITIVITY 56
45 PRODUCT USE IN UNAPPROVED INDICATION 56
46 PAIN IN EXTREMITY 55
47 PRODUCT DELIVERY MECHANISM ISSUE 53
48 ASTHENIA 52
49 INFLUENZA 52
50 BACK PAIN 51
51 FEELING ABNORMAL 51
52 ILLNESS 50
53 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 49
54 INJECTION SITE PAIN 49
55 RENAL IMPAIRMENT 49
56 HEPATIC FUNCTION ABNORMAL 48
57 HYPERTENSION 47
58 INTERSTITIAL LUNG DISEASE 46
59 PLATELET COUNT DECREASED 46
60 RHINORRHOEA 46
61 URTICARIA 45
62 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 45
63 ANXIETY 44
64 PRODUCT USE ISSUE 44
65 CONSTIPATION 42
66 DRY SKIN 42
67 VISUAL IMPAIRMENT 42
68 PRODUCTIVE COUGH 41
69 DEATH 40
70 NO ADVERSE EVENT 40
71 WHITE BLOOD CELL COUNT DECREASED 39
72 PRODUCT PHYSICAL CONSISTENCY ISSUE 38
73 HYPOTENSION 37
74 NEUTROPHIL COUNT DECREASED 37
75 OROPHARYNGEAL PAIN 36
76 FEBRILE NEUTROPENIA 35
77 LIQUID PRODUCT PHYSICAL ISSUE 35
78 NASAL CONGESTION 35
79 SEPSIS 35
80 ABDOMINAL PAIN 34
81 BLOOD PRESSURE DECREASED 34
82 CHEST DISCOMFORT 34
83 CONJUNCTIVITIS 34
84 EYELID MARGIN CRUSTING 34
85 PERIPHERAL SWELLING 34
86 GAIT DISTURBANCE 33
87 JOINT SWELLING 33
88 MUSCLE SPASMS 33
89 OEDEMA PERIPHERAL 33
90 DEHYDRATION 32
91 INFUSION RELATED REACTION 32
92 PRODUCT QUALITY ISSUE 32
93 BLOOD PRESSURE INCREASED 31
94 DRUG ERUPTION 31
95 MIGRAINE 31
96 SEASONAL ALLERGY 31
97 ABDOMINAL DISCOMFORT 30
98 CARDIAC DISORDER 30
99 CHEST PAIN 30
100 DEPRESSION 30
101 FOREIGN BODY SENSATION IN EYES 30
102 ABDOMINAL PAIN UPPER 29
103 CARDIAC FAILURE 29
104 ECZEMA 29
105 HEART RATE INCREASED 29
106 HYPOAESTHESIA 29
107 SWELLING OF EYELID 29
108 ACCIDENTAL OVERDOSE 28
109 CELLULITIS 28
110 SKIN EXFOLIATION 27
111 VIRAL INFECTION 27
112 HERPES ZOSTER 26
113 BLOOD CHOLESTEROL INCREASED 25
114 BLOOD PRESSURE FLUCTUATION 25
115 DRUG EFFECT LESS THAN EXPECTED 25
116 DYSGEUSIA 25
117 EAR INFECTION 25
118 EXPIRED PRODUCT ADMINISTERED 25
119 OXYGEN SATURATION DECREASED 25
120 PRODUCT PACKAGING QUANTITY ISSUE 25
121 EPISTAXIS 24
122 ERYTHEMA MULTIFORME 24
123 INCORRECT DOSE ADMINISTERED 24
124 INFLUENZA LIKE ILLNESS 24
125 OVERDOSE 24
126 ANAPHYLACTIC REACTION 23
127 FUNGAL INFECTION 23
128 INFECTION 23
129 MALIGNANT NEOPLASM PROGRESSION 23
130 MYALGIA 23
131 PHOTOPHOBIA 23
132 SOMNOLENCE 23
133 ALANINE AMINOTRANSFERASE INCREASED 22
134 ERYTHEMA OF EYELID 22
135 HAEMOGLOBIN DECREASED 22
136 MUSCULAR WEAKNESS 22
137 OEDEMA 22
138 PALPITATIONS 22
139 PARAESTHESIA 22
140 WHEEZING 22
141 ABNORMAL SENSATION IN EYE 21
142 ATRIAL FIBRILLATION 21
143 DERMATITIS ATOPIC 21
144 DIVERTICULITIS 21
145 EYE DISORDER 21
146 GASTROOESOPHAGEAL REFLUX DISEASE 21
147 INFUSION SITE PAIN 21
148 LIVER DISORDER 21
149 TREMOR 21
150 UPPER RESPIRATORY TRACT INFECTION 21
151 ABDOMINAL DISTENSION 20
152 ACUTE KIDNEY INJURY 20
153 ALOPECIA 20
154 DYSPNOEA EXERTIONAL 20
155 INFUSION SITE ERYTHEMA 20
156 INJECTION SITE ERYTHEMA 20
157 INJECTION SITE SWELLING 20
158 NEUTROPENIA 20
159 PNEUMONIA ASPIRATION 20
160 SKIN ULCER 20
161 C-REACTIVE PROTEIN INCREASED 19
162 PATIENT DISSATISFACTION WITH TREATMENT 19
163 PRODUCT CONTAINER ISSUE 19
164 RHEUMATOID ARTHRITIS 19
165 SWELLING 19
166 THERAPEUTIC PRODUCT EFFECT DECREASED 19
167 THROMBOCYTOPENIA 19
168 DYSPHAGIA 18
169 EYE INFECTION 18
170 FLUSHING 18
171 GENERAL PHYSICAL HEALTH DETERIORATION 18
172 HYPERHIDROSIS 18
173 NEURALGIA 18
174 PRODUCT ODOUR ABNORMAL 18
175 PRODUCT SUBSTITUTION ISSUE 18
176 RENAL FAILURE 18
177 TACHYCARDIA 18
178 ASPARTATE AMINOTRANSFERASE INCREASED 17
179 CATARACT 17
180 CHILLS 17
181 DRUG INTERACTION 17
182 DRY MOUTH 17
183 HEPATIC ENZYME INCREASED 17
184 HYPOKALAEMIA 17
185 LOSS OF CONSCIOUSNESS 17
186 PEMPHIGOID 17
187 PRODUCT USE COMPLAINT 17
188 SLEEP DISORDER 17
189 STOMATITIS 17
190 TINNITUS 17
191 BLOOD PRESSURE SYSTOLIC ABNORMAL 16
192 BLOOD PRESSURE SYSTOLIC INCREASED 16
193 CEREBRAL INFARCTION 16
194 GASTROINTESTINAL DISORDER 16
195 INJECTION SITE PRURITUS 16
196 MULTIPLE ALLERGIES 16
197 MYOCARDIAL INFARCTION 16
198 NECK PAIN 16
199 NEUROPATHY PERIPHERAL 16
200 PLEURAL EFFUSION 16
201 ADRENAL INSUFFICIENCY 15
202 ALTERED STATE OF CONSCIOUSNESS 15
203 BLOOD CREATININE INCREASED 15
204 CARDIAC FAILURE CONGESTIVE 15
205 DISSEMINATED INTRAVASCULAR COAGULATION 15
206 DRUG-INDUCED LIVER INJURY 15
207 HOT FLUSH 15
208 LIMB INJURY 15
209 PERIORBITAL SWELLING 15
210 SINUS DISORDER 15
211 SKIN FISSURES 15
212 STEVENS-JOHNSON SYNDROME 15
213 SURGERY 15
214 BURNING SENSATION 14
215 CONJUNCTIVITIS ALLERGIC 14
216 DYSPHONIA 14
217 HYPOXIA 14
218 INFUSION SITE SWELLING 14
219 LUNG DISORDER 14
220 MEMORY IMPAIRMENT 14
221 PANCYTOPENIA 14
222 SEIZURE 14
223 SEPTIC SHOCK 14
224 ACCIDENTAL EXPOSURE TO PRODUCT 13
225 ARTHRITIS 13
226 CONTUSION 13
227 DEEP VEIN THROMBOSIS 13
228 DEPRESSED LEVEL OF CONSCIOUSNESS 13
229 DYSPEPSIA 13
230 EAR PAIN 13
231 EYELID IRRITATION 13
232 INFUSION SITE PRURITUS 13
233 INJECTION SITE BRUISING 13
234 INTENTIONAL DOSE OMISSION 13
235 RASH ERYTHEMATOUS 13
236 RESPIRATORY DISORDER 13
237 STAPHYLOCOCCAL INFECTION 13
238 SWELLING FACE 13
239 THERAPY NON-RESPONDER 13
240 THROAT IRRITATION 13
241 ADVERSE DRUG REACTION 12
242 BACTERIAL INFECTION 12
243 BLISTER 12
244 CHOLANGITIS 12
245 DEVICE LEAKAGE 12
246 DIABETES MELLITUS 12
247 HAEMORRHAGE 12
248 HYPOTHYROIDISM 12
249 INTENTIONAL PRODUCT MISUSE 12
250 INTENTIONAL PRODUCT USE ISSUE 12
251 LYMPHADENOPATHY 12
252 PHARYNGITIS 12
253 PSORIASIS 12
254 PULMONARY MASS 12
255 RESPIRATORY TRACT INFECTION 12
256 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12
257 THERAPEUTIC RESPONSE DECREASED 12
258 THERAPEUTIC RESPONSE SHORTENED 12
259 TYPE 2 DIABETES MELLITUS 12
260 UNDERDOSE 12
261 BLOOD CREATINE PHOSPHOKINASE INCREASED 11
262 BLOOD LACTATE DEHYDROGENASE INCREASED 11
263 CANDIDA INFECTION 11
264 CONTRAINDICATED PRODUCT ADMINISTERED 11
265 CYSTITIS 11
266 DELIRIUM 11
267 DISCOMFORT 11
268 DISEASE PROGRESSION 11
269 EYELIDS PRURITUS 11
270 FEELING HOT 11
271 GASTRITIS 11
272 GASTROINTESTINAL HAEMORRHAGE 11
273 HYPERURICAEMIA 11
274 LEUKOPENIA 11
275 LOCALISED INFECTION 11
276 MELAENA 11
277 MIDDLE INSOMNIA 11
278 MOBILITY DECREASED 11
279 ORAL HERPES 11
280 PRODUCT PACKAGING ISSUE 11
281 RASH MACULAR 11
282 WRONG PRODUCT ADMINISTERED 11
283 BLOOD BILIRUBIN INCREASED 10
284 BODY TEMPERATURE DECREASED 10
285 CEREBROVASCULAR ACCIDENT 10
286 CYTOKINE RELEASE SYNDROME 10
287 DRUG INTOLERANCE 10
288 EOSINOPHIL COUNT INCREASED 10
289 EYE ALLERGY 10
290 GASTROENTERITIS 10
291 HEPATIC STEATOSIS 10
292 HYPOPHAGIA 10
293 INFUSION SITE HAEMORRHAGE 10
294 INJURY 10
295 INTESTINAL OBSTRUCTION 10
296 IRRITABILITY 10
297 LIGAMENT SPRAIN 10
298 MUSCULOSKELETAL STIFFNESS 10
299 MYELODYSPLASTIC SYNDROME 10
300 ORAL CANDIDIASIS 10
301 OSTEOPOROSIS 10
302 POOR VENOUS ACCESS 10
303 PRODUCT ADMINISTRATION ERROR 10
304 PULMONARY ARTERIAL HYPERTENSION 10
305 RASH GENERALISED 10
306 RASH PRURITIC 10
307 RENAL COLIC 10
308 RHABDOMYOLYSIS 10
309 RHINITIS ALLERGIC 10
310 TASTE DISORDER 10
311 THERAPY INTERRUPTED 10
312 URINARY RETENTION 10
313 AGITATION 9
314 ARTHROPATHY 9
315 BALANCE DISORDER 9
316 BLOOD GLUCOSE INCREASED 9
317 BLOOD POTASSIUM DECREASED 9
318 BLOOD PRESSURE DIASTOLIC INCREASED 9
319 BREAST CANCER 9
320 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9
321 CONFUSIONAL STATE 9
322 DEVICE INFUSION ISSUE 9
323 EMOTIONAL DISTRESS 9
324 EXPOSURE VIA SKIN CONTACT 9
325 EYE HAEMORRHAGE 9
326 FIBROMYALGIA 9
327 FLUID RETENTION 9
328 FOOT FRACTURE 9
329 HEPATIC FAILURE 9
330 HYPERKALAEMIA 9
331 HYPONATRAEMIA 9
332 INFLAMMATION 9
333 INFUSION SITE BRUISING 9
334 INJECTION SITE EXTRAVASATION 9
335 LIP SWELLING 9
336 MUSCULOSKELETAL PAIN 9
337 MYELOSUPPRESSION 9
338 PHARYNGITIS STREPTOCOCCAL 9
339 PNEUMOTHORAX 9
340 PRESCRIBED UNDERDOSE 9
341 PRESYNCOPE 9
342 RESTLESS LEGS SYNDROME 9
343 SECRETION DISCHARGE 9
344 SINUS CONGESTION 9
345 SJOGREN^S SYNDROME 9
346 SKIN IRRITATION 9
347 SLEEP APNOEA SYNDROME 9
348 SPINAL COMPRESSION FRACTURE 9
349 STRESS 9
350 SUICIDAL IDEATION 9
351 WOUND 9
352 ABNORMAL BEHAVIOUR 8
353 ACUTE MYELOID LEUKAEMIA 8
354 ASCITES 8
355 BLOOD GLUCOSE ABNORMAL 8
356 BLOOD UREA INCREASED 8
357 CEREBRAL HAEMORRHAGE 8
358 CHRONIC KIDNEY DISEASE 8
359 COMA 8
360 DERMATITIS CONTACT 8
361 DERMATITIS EXFOLIATIVE GENERALISED 8
362 DEVICE DEFECTIVE 8
363 DEVICE RELATED INFECTION 8
364 DRUG DOSE OMISSION 8
365 EXTRA DOSE ADMINISTERED 8
366 EYE INFLAMMATION 8
367 EYELID PAIN 8
368 FEEDING DISORDER 8
369 HAEMATOCHEZIA 8
370 HAEMOPTYSIS 8
371 HALLUCINATION 8
372 INFUSION SITE DISCHARGE 8
373 INJECTION SITE MASS 8
374 INSURANCE ISSUE 8
375 NEPHROLITHIASIS 8
376 OROPHARYNGEAL DISCOMFORT 8
377 OSTEOARTHRITIS 8
378 POLLAKIURIA 8
379 POLYP 8
380 PRODUCT AVAILABILITY ISSUE 8
381 PRODUCT DOSE OMISSION 8
382 PRODUCT PACKAGING DIFFICULT TO OPEN 8
383 PRODUCT SIZE ISSUE 8
384 RENAL DISORDER 8
385 RESPIRATORY FAILURE 8
386 RESTLESSNESS 8
387 SCAB 8
388 SKIN HAEMORRHAGE 8
389 SYNCOPE 8
390 TOOTH INFECTION 8
391 TOOTHACHE 8
392 TREATMENT NONCOMPLIANCE 8
393 TUBULOINTERSTITIAL NEPHRITIS 8
394 VERTIGO 8
395 WHITE BLOOD CELL COUNT INCREASED 8
396 ADVERSE REACTION 7
397 AGGRESSION 7
398 ANAPHYLACTIC SHOCK 7
399 AUTOIMMUNE DISORDER 7
400 BACK DISORDER 7
401 BLINDNESS 7
402 BLOOD ALKALINE PHOSPHATASE INCREASED 7
403 BRAIN FOG 7
404 BREATH SOUNDS ABNORMAL 7
405 CARDIO-RESPIRATORY ARREST 7
406 CHROMATURIA 7
407 CRYING 7
408 DEAFNESS 7
409 DERMATITIS ACNEIFORM 7
410 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7
411 FEAR 7
412 FOOD POISONING 7
413 GASTRIC ULCER 7
414 GASTROINTESTINAL INFECTION 7
415 HYPOAESTHESIA EYE 7
416 INTERNATIONAL NORMALISED RATIO INCREASED 7
417 IRRITABLE BOWEL SYNDROME 7
418 JAUNDICE 7
419 KIDNEY INFECTION 7
420 LIGAMENT RUPTURE 7
421 MADAROSIS 7
422 MITRAL VALVE DISEASE 7
423 PANCREATITIS 7
424 PANIC ATTACK 7
425 PARONYCHIA 7
426 PNEUMONIA BACTERIAL 7
427 PRODUCT ADMINISTRATION INTERRUPTED 7
428 PRODUCT AFTER TASTE 7
429 PRODUCT CLOSURE REMOVAL DIFFICULT 7
430 PRODUCT COLOUR ISSUE 7
431 PRODUCT DISTRIBUTION ISSUE 7
432 PRODUCT DOSE OMISSION IN ERROR 7
433 PRODUCT LABEL ISSUE 7
434 PRODUCT PACKAGE ASSOCIATED INJURY 7
435 PSEUDOMONAS INFECTION 7
436 PULMONARY CONGESTION 7
437 PULMONARY EMBOLISM 7
438 RECTAL HAEMORRHAGE 7
439 SCIATICA 7
440 SHOCK 7
441 SUICIDE ATTEMPT 7
442 SYSTEMIC LUPUS ERYTHEMATOSUS 7
443 THIRST 7
444 UPPER RESPIRATORY TRACT INFLAMMATION 7
445 URTICARIAL VASCULITIS 7
446 UVEITIS 7
447 AMNESIA 6
448 ANKLE FRACTURE 6
449 APHTHOUS ULCER 6
450 BLEPHARITIS 6
451 BLOOD POTASSIUM INCREASED 6
452 BLOOD PRESSURE ABNORMAL 6
453 BLOOD PRESSURE SYSTOLIC DECREASED 6
454 BLOOD SODIUM DECREASED 6
455 BODY HEIGHT DECREASED 6
456 BRONCHIECTASIS 6
457 CHRONIC SINUSITIS 6
458 COMPLETED SUICIDE 6
459 COVID-19 PNEUMONIA 6
460 CYANOSIS 6
461 DEVICE ISSUE 6
462 DISTURBANCE IN ATTENTION 6
463 EAR DISORDER 6
464 ENCEPHALOPATHY 6
465 EOSINOPHILIA 6
466 EYELID INFECTION 6
467 EYELID OEDEMA 6
468 EYELID RASH 6
469 FEELING JITTERY 6
470 GAIT INABILITY 6
471 HAEMATEMESIS 6
472 HAEMORRHOIDS 6
473 HEAD INJURY 6
474 HEART RATE DECREASED 6
475 HEREDITARY ANGIOEDEMA 6
476 HOSPITALISATION 6
477 HYPERGLYCAEMIA 6
478 HYPOCALCAEMIA 6
479 HYPOGAMMAGLOBULINAEMIA 6
480 HYPOGLYCAEMIA 6
481 ILL-DEFINED DISORDER 6
482 INCORRECT PRODUCT ADMINISTRATION DURATION 6
483 INJECTION SITE HAEMORRHAGE 6
484 INJECTION SITE REACTION 6
485 INTERNAL HAEMORRHAGE 6
486 INTRAOCULAR PRESSURE INCREASED 6
487 LACTIC ACIDOSIS 6
488 LIP EROSION 6
489 LYMPHOCYTE COUNT DECREASED 6
490 MITRAL VALVE INCOMPETENCE 6
491 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6
492 NASAL DISCOMFORT 6
493 NEOPLASM MALIGNANT 6
494 NERVOUSNESS 6
495 PAIN OF SKIN 6
496 PALLOR 6
497 PERICARDIAL EFFUSION 6
498 PERIPHERAL SENSORY NEUROPATHY 6
499 PHOTOPSIA 6
500 PNEUMOCYSTIS JIROVECII PNEUMONIA 6
501 POST PROCEDURAL INFECTION 6
502 PRODUCT CONTAINER SEAL ISSUE 6
503 PRODUCT DISPENSING ERROR 6
504 PRODUCT LEAKAGE 6
505 PRODUCT STORAGE ERROR 6
506 PROTEINURIA 6
507 PULMONARY OEDEMA 6
508 RASH MACULO-PAPULAR 6
509 REBOUND EFFECT 6
510 RENAL FAILURE ACUTE 6
511 SARS-COV-2 TEST POSITIVE 6
512 SENSATION OF FOREIGN BODY 6
513 SKIN DISCOLOURATION 6
514 SKIN EROSION 6
515 SKIN SWELLING 6
516 SKIN WEEPING 6
517 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6
518 STICKY SKIN 6
519 TENDERNESS 6
520 THROAT TIGHTNESS 6
521 THROMBOSIS 6
522 TOXIC SKIN ERUPTION 6
523 VEIN COLLAPSE 6
524 WRONG PRODUCT PROCURED 6
525 ADVERSE EVENT 5
526 ALOPECIA AREATA 5
527 ANGER 5
528 ARRHYTHMIA 5
529 BLOOD COUNT ABNORMAL 5
530 BLOOD GLUCOSE DECREASED 5
531 BLOOD IMMUNOGLOBULIN G DECREASED 5
532 BLOOD PRESSURE DIASTOLIC ABNORMAL 5
533 BLOOD PRESSURE DIASTOLIC DECREASED 5
534 BRADYCARDIA 5
535 BREAST MASS 5
536 CHOKING 5
537 CHOLECYSTITIS 5
538 CHOLECYSTITIS CHRONIC 5
539 CLOSTRIDIUM DIFFICILE INFECTION 5
540 COLD SWEAT 5
541 COLITIS 5
542 CROHN^S DISEASE 5
543 CYTOMEGALOVIRUS INFECTION 5
544 DEMENTIA 5
545 DERMATITIS 5
546 DEVICE BREAKAGE 5
547 DEVICE MALFUNCTION 5
548 DIPLOPIA 5
549 DISORIENTATION 5
550 DYSKINESIA 5
551 ELECTROCARDIOGRAM QT PROLONGED 5
552 ENTERITIS INFECTIOUS 5
553 EPILEPSY 5
554 EXPOSURE DURING PREGNANCY 5
555 EXPOSURE TO ALLERGEN 5
556 EYELID DISORDER 5
557 EYELID EXFOLIATION 5
558 FAECES DISCOLOURED 5
559 FEMUR FRACTURE 5
560 GALLBLADDER DISORDER 5
561 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5
562 GENERALISED OEDEMA 5
563 HAEMATURIA 5
564 HAEMOGLOBIN INCREASED 5
565 HEPATIC CIRRHOSIS 5
566 HERPES VIRUS INFECTION 5
567 HORDEOLUM 5
568 HUMIDITY INTOLERANCE 5
569 HYPOACUSIS 5
570 HYPOMAGNESAEMIA 5
571 ILEUS 5
572 IMMUNE-MEDIATED ENTEROCOLITIS 5
573 IMMUNE-MEDIATED HEPATIC DISORDER 5
574 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5
575 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5
576 INCREASED UPPER AIRWAY SECRETION 5
577 INFUSION SITE REACTION 5
578 INITIAL INSOMNIA 5
579 INJECTION SITE RASH 5
580 INJECTION SITE URTICARIA 5
581 INTESTINAL PERFORATION 5
582 LABORATORY TEST ABNORMAL 5
583 LETHARGY 5
584 LUNG NEOPLASM MALIGNANT 5
585 MULTIPLE SCLEROSIS RELAPSE 5
586 MUSCLE STRAIN 5
587 MUSCULOSKELETAL DISCOMFORT 5
588 MYOFASCIAL PAIN SYNDROME 5
589 NEOPLASM 5
590 NEOPLASM PROGRESSION 5
591 NEPHROGENIC ANAEMIA 5
592 ORAL DISCOMFORT 5
593 PAIN IN JAW 5
594 PANCREATITIS ACUTE 5
595 PNEUMONIA INFLUENZAL 5
596 POST PROCEDURAL COMPLICATION 5
597 PROCEDURAL PAIN 5
598 PRODUCT COMPLAINT 5
599 PRODUCT OUTER PACKAGING ISSUE 5
600 PRODUCT WITH QUALITY ISSUE ADMINISTERED 5
601 PYELONEPHRITIS 5
602 PYELONEPHRITIS ACUTE 5
603 RED BLOOD CELL COUNT DECREASED 5
604 RESPIRATORY SYMPTOM 5
605 RESPIRATORY TRACT CONGESTION 5
606 RESPIRATORY TRACT INFECTION VIRAL 5
607 RHINITIS 5
608 ROTATOR CUFF SYNDROME 5
609 SINUS HEADACHE 5
610 SINUSITIS BACTERIAL 5
611 SKIN LACERATION 5
612 SNEEZING 5
613 SPINAL OPERATION 5
614 THERAPEUTIC PRODUCT INEFFECTIVE 5
615 THERMAL BURN 5
616 TOTAL CHOLESTEROL/HDL RATIO ABNORMAL 5
617 TOXIC EPIDERMAL NECROLYSIS 5
618 TYMPANIC MEMBRANE PERFORATION 5
619 UNEVALUABLE EVENT 5
620 UPPER LIMB FRACTURE 5
621 URINARY INCONTINENCE 5
622 VASCULAR DEVICE INFECTION 5
623 WRIST FRACTURE 5
624 ACCIDENT 4
625 ACNE 4
626 ALLERGIC REACTION TO EXCIPIENT 4
627 AMYLASE INCREASED 4
628 ANGIOEDEMA 4
629 APPENDICITIS 4
630 ARTERIOSCLEROSIS 4
631 ASPHYXIA 4
632 ATAXIA 4
633 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 4
634 AZOTAEMIA 4
635 BACTERAEMIA 4
636 BLEPHAROSPASM 4
637 BLOOD ALBUMIN DECREASED 4
638 BLOOD IRON DECREASED 4
639 BLOOD URINE PRESENT 4
640 BONE PAIN 4
641 CARDIAC ARREST 4
642 CARDIAC MURMUR 4
643 CATHETERISATION CARDIAC 4
644 CIRCULATORY COLLAPSE 4
645 COLORECTAL CANCER 4
646 COMPRESSION FRACTURE 4
647 CORONARY ARTERY STENOSIS 4
648 CYTOMEGALOVIRUS ENTEROCOLITIS 4
649 CYTOMEGALOVIRUS TEST POSITIVE 4
650 DELUSION 4
651 DERMATITIS ALLERGIC 4
652 DEVELOPMENTAL DELAY 4
653 DRUG ABUSE 4
654 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4
655 DRUG EXPOSURE DURING PREGNANCY 4
656 DYSARTHRIA 4
657 DYSURIA 4
658 EAR DISCOMFORT 4
659 EATING DISORDER 4
660 ECZEMA HERPETICUM 4
661 ELECTROLYTE IMBALANCE 4
662 EMBOLIC STROKE 4
663 EMOTIONAL DISORDER 4
664 EUPHORIC MOOD 4
665 EXERCISE TOLERANCE DECREASED 4
666 FACE OEDEMA 4
667 FACIAL DISCOMFORT 4
668 FIBULA FRACTURE 4
669 GASTRIC CANCER 4
670 GENERALISED ERYTHEMA 4
671 GLAUCOMA 4
672 GLOSSITIS 4
673 GLUCOSE TOLERANCE IMPAIRED 4
674 GLYCOSYLATED HAEMOGLOBIN INCREASED 4
675 HEAD DISCOMFORT 4
676 HEART RATE IRREGULAR 4
677 HEPATITIS 4
678 HIP FRACTURE 4
679 HYPERAMMONAEMIA 4
680 HYPERTONIC BLADDER 4
681 HYPERTRIGLYCERIDAEMIA 4
682 IMPAIRED HEALING 4
683 IMPULSIVE BEHAVIOUR 4
684 INJECTION SITE DISCOLOURATION 4
685 INJECTION SITE INDURATION 4
686 INTERNATIONAL NORMALISED RATIO DECREASED 4
687 KERATOCONUS 4
688 LICHENIFICATION 4
689 LIP INJURY 4
690 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4
691 MACULAR OEDEMA 4
692 MENTAL DISORDER 4
693 METABOLIC ENCEPHALOPATHY 4
694 MOUTH ULCERATION 4
695 NEPHROGENIC SYSTEMIC FIBROSIS 4
696 NEUTROPHIL COUNT INCREASED 4
697 OBSTRUCTION 4
698 ORAL MUCOSA EROSION 4
699 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4
700 PARAESTHESIA ORAL 4
701 PERIORBITAL PAIN 4
702 PNEUMONITIS 4
703 POOR QUALITY SLEEP 4
704 PRESCRIBED OVERDOSE 4
705 PRODUCT DISPENSING ISSUE 4
706 PRODUCT LABEL CONFUSION 4
707 PRODUCT PRESCRIBING ERROR 4
708 PRODUCT RESIDUE PRESENT 4
709 PROTHROMBIN TIME PROLONGED 4
710 PULMONARY TOXICITY 4
711 RALES 4
712 RESPIRATORY DISTRESS 4
713 RETCHING 4
714 RIB FRACTURE 4
715 RUBBER SENSITIVITY 4
716 SKIN DISORDER 4
717 SKIN INFECTION 4
718 SKIN LESION 4
719 SUPERFICIAL INJURY OF EYE 4
720 THERAPY CESSATION 4
721 THERAPY PARTIAL RESPONDER 4
722 THROMBOTIC CEREBRAL INFARCTION 4
723 THYROIDITIS 4
724 TIBIA FRACTURE 4
725 TUMOUR LYSIS SYNDROME 4
726 TYPE 1 DIABETES MELLITUS 4
727 UPPER-AIRWAY COUGH SYNDROME 4
728 VITREOUS DETACHMENT 4
729 WEIGHT FLUCTUATION 4
730 ABDOMINAL PAIN LOWER 3
731 ABNORMAL DREAMS 3
732 ACIDOSIS 3
733 ACUTE RESPIRATORY DISTRESS SYNDROME 3
734 ACUTE RESPIRATORY FAILURE 3
735 ADMINISTRATION SITE PAIN 3
736 AGEUSIA 3
737 ANAPHYLACTOID REACTION 3
738 ANGINA PECTORIS 3
739 ANKYLOSING SPONDYLITIS 3
740 APHASIA 3
741 APHONIA 3
742 ARTHROPOD STING 3
743 ASTHENOPIA 3
744 ATRIOVENTRICULAR BLOCK COMPLETE 3
745 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3
746 ATYPICAL PNEUMONIA 3
747 AUTOIMMUNE HEPATITIS 3
748 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3
749 BLOOD BETA-D-GLUCAN INCREASED 3
750 BLOOD PHOSPHORUS DECREASED 3
751 BLOOD THYROID STIMULATING HORMONE INCREASED 3
752 BLOOD TRIGLYCERIDES INCREASED 3
753 BONE MARROW OEDEMA 3
754 BRAIN OEDEMA 3
755 BREAST CANCER FEMALE 3
756 BRONCHIAL HYPERREACTIVITY 3
757 BRONCHOSPASM 3
758 CAESAREAN SECTION 3
759 CARDIAC FAILURE ACUTE 3
760 CARDIAC FLUTTER 3
761 CARDIOVASCULAR DISORDER 3
762 CARDIOVASCULAR SYMPTOM 3
763 CHAPPED LIPS 3
764 CHOLECYSTECTOMY 3
765 CHOLECYSTITIS ACUTE 3
766 CLEFT PALATE 3
767 COELIAC DISEASE 3
768 COLITIS ISCHAEMIC 3
769 COLITIS ULCERATIVE 3
770 CONCOMITANT DISEASE AGGRAVATED 3
771 CONCOMITANT DISEASE PROGRESSION 3
772 CORYNEBACTERIUM SEPSIS 3
773 CRANIOSYNOSTOSIS 3
774 CYST 3
775 CYTOMEGALOVIRUS VIRAEMIA 3
776 CYTOPENIA 3
777 DEFAECATION URGENCY 3
778 DERMATITIS BULLOUS 3
779 DEVICE FAILURE 3
780 DEVICE PHYSICAL PROPERTY ISSUE 3
781 DEVICE USE ISSUE 3
782 DIABETIC KETOACIDOSIS 3
783 DIARRHOEA HAEMORRHAGIC 3
784 DISABILITY 3
785 DISORDER OF ORBIT 3
786 DISSEMINATED TUBERCULOSIS 3
787 DRUG EFFECT DECREASED 3
788 DRUG EFFECT INCOMPLETE 3
789 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3
790 DYSMORPHISM 3
791 DYSSTASIA 3
792 EAR PRURITUS 3
793 EAR SWELLING 3
794 ELECTROCARDIOGRAM ABNORMAL 3
795 EMBOLISM 3
796 ENTERITIS 3
797 EYELID BLEEDING 3
798 FAECES SOFT 3
799 FEELING COLD 3
800 FLATULENCE 3
801 FLUID INTAKE REDUCED 3
802 FOOD ALLERGY 3
803 FOOT DEFORMITY 3
804 FRACTURE 3
805 FRUSTRATION TOLERANCE DECREASED 3
806 FULMINANT TYPE 1 DIABETES MELLITUS 3
807 FUNGAL SKIN INFECTION 3
808 GASTROENTERITIS VIRAL 3
809 GASTROINTESTINAL INFLAMMATION 3
810 GENERALISED TONIC-CLONIC SEIZURE 3
811 GINGIVAL BLEEDING 3
812 GINGIVITIS 3
813 GLOMERULAR FILTRATION RATE DECREASED 3
814 HAEMATOCRIT DECREASED 3
815 HAEMOLYTIC ANAEMIA 3
816 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3
817 HEAT ILLNESS 3
818 HEPATIC ENCEPHALOPATHY 3
819 HEPATOCELLULAR CARCINOMA 3
820 HIATUS HERNIA 3
821 HICCUPS 3
822 HYPERBILIRUBINAEMIA 3
823 HYPOAESTHESIA ORAL 3
824 HYPOALBUMINAEMIA 3
825 HYSTERECTOMY 3
826 IMMUNE-MEDIATED MYOCARDITIS 3
827 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3
828 INCORRECT DOSAGE ADMINISTERED 3
829 INFUSION SITE DISCOMFORT 3
830 INFUSION SITE EXTRAVASATION 3
831 INFUSION SITE IRRITATION 3
832 INJECTION SITE DISCOMFORT 3
833 INTENTIONAL OVERDOSE 3
834 INTERVERTEBRAL DISC DEGENERATION 3
835 IRON DEFICIENCY 3
836 JOINT INJURY 3
837 JOINT STIFFNESS 3
838 KNEE ARTHROPLASTY 3
839 LIMB DISCOMFORT 3
840 LIPASE INCREASED 3
841 LOWER RESPIRATORY TRACT INFECTION 3
842 LUNG ABSCESS 3
843 LUNG INFECTION 3
844 LYMPHOMA 3
845 MACULAR DEGENERATION 3
846 MANUFACTURING ISSUE 3
847 MENOPAUSAL SYMPTOMS 3
848 METASTASES TO BONE 3
849 METASTASES TO LUNG 3
850 MONOCYTE COUNT INCREASED 3
851 MULTI-ORGAN FAILURE 3
852 MUSCULOSKELETAL CHEST PAIN 3
853 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3
854 MYDRIASIS 3
855 MYOCLONUS 3
856 NAIL DISORDER 3
857 NASAL DRYNESS 3
858 NASAL POLYPS 3
859 NEEDLE ISSUE 3
860 NEPHROTIC SYNDROME 3
861 NERVOUS SYSTEM DISORDER 3
862 NOCTURIA 3
863 OESOPHAGEAL CANDIDIASIS 3
864 OESOPHAGITIS 3
865 ORAL INFECTION 3
866 ORAL PAIN 3
867 ORAL PRURITUS 3
868 ORGANISING PNEUMONIA 3
869 ORTHOSTATIC HYPOTENSION 3
870 OSTEONECROSIS 3
871 OTITIS EXTERNA 3
872 PARANASAL CYST 3
873 PAROSMIA 3
874 PERIPHERAL COLDNESS 3
875 PERITONITIS 3
876 PHARYNGEAL SWELLING 3
877 PHLEBITIS 3
878 PHOTOSENSITIVITY REACTION 3
879 PHYSICAL DECONDITIONING 3
880 PIERRE ROBIN SYNDROME 3
881 POST HERPETIC NEURALGIA 3
882 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3
883 PREGNANCY 3
884 PRODUCT ADVERTISING ISSUE 3
885 PRODUCT DESIGN ISSUE 3
886 PRODUCT LOT NUMBER ISSUE 3
887 PRODUCT PHYSICAL ISSUE 3
888 PRODUCT SELECTION ERROR 3
889 PRODUCT TASTE ABNORMAL 3
890 PRURITUS GENERALISED 3
891 PULMONARY HYPERTENSION 3
892 PUNCTATE KERATITIS 3
893 RASH PAPULAR 3
894 RECTAL CANCER 3
895 RED CELL DISTRIBUTION WIDTH INCREASED 3
896 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3
897 RESPIRATORY TRACT IRRITATION 3
898 RETINAL HAEMORRHAGE 3
899 ROAD TRAFFIC ACCIDENT 3
900 ROSACEA 3
901 SACROILIITIS 3
902 SCHIZOPHRENIA 3
903 SCLERODERMA RENAL CRISIS 3
904 SCRATCH 3
905 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3
906 SINUS OPERATION 3
907 SKIN BURNING SENSATION 3
908 SKIN MASS 3
909 SKIN WARM 3
910 SMALL INTESTINAL OBSTRUCTION 3
911 SPEECH DISORDER 3
912 STAPHYLOCOCCAL SEPSIS 3
913 SUBDURAL HAEMATOMA 3
914 SUDDEN HEARING LOSS 3
915 SUPRAVENTRICULAR TACHYCARDIA 3
916 SUSPECTED PRODUCT CONTAMINATION 3
917 SWOLLEN TONGUE 3
918 SYNOVITIS 3
919 THALAMUS HAEMORRHAGE 3
920 THERAPEUTIC PRODUCT EFFECT DELAYED 3
921 THERAPEUTIC RESPONSE UNEXPECTED 3
922 THYROIDITIS SUBACUTE 3
923 TONGUE ERYTHEMA 3
924 TONGUE INJURY 3
925 TOOTH DISORDER 3
926 TORTICOLLIS 3
927 TOXIC ENCEPHALOPATHY 3
928 TRANSIENT ISCHAEMIC ATTACK 3
929 ULCER 3
930 UPPER RESPIRATORY TRACT CONGESTION 3
931 UROSEPSIS 3
932 VASCULITIS 3
933 VISUAL ACUITY REDUCED 3
934 VITREOUS FLOATERS 3
935 VULVOVAGINAL MYCOTIC INFECTION 3
936 WHITE BLOOD CELLS URINE POSITIVE 3
937 ABASIA 2
938 ABSCESS 2
939 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2
940 ACUTE MYOCARDIAL INFARCTION 2
941 ACUTE SINUSITIS 2
942 ADMINISTRATION SITE SWELLING 2
943 ADULT T-CELL LYMPHOMA/LEUKAEMIA 2
944 AGRANULOCYTOSIS 2
945 ALLERGY TO ANIMAL 2
946 ALLERGY TO ARTHROPOD BITE 2
947 ALOPECIA UNIVERSALIS 2
948 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 2
949 ANAL ABSCESS 2
950 ANAL FISSURE 2
951 ANEURYSM 2
952 ANIMAL BITE 2
953 ANOREXIA 2
954 ANTITHROMBIN III DECREASED 2
955 ANURIA 2
956 AORTIC DISSECTION 2
957 AORTIC VALVE CALCIFICATION 2
958 AORTIC VALVE STENOSIS 2
959 AORTIC VALVE THICKENING 2
960 APPLICATION SITE ERYTHEMA 2
961 APPLICATION SITE PAIN 2
962 APPLICATION SITE PRURITUS 2
963 APRAXIA 2
964 ARTHROPOD BITE 2
965 ASPERGILLUS TEST POSITIVE 2
966 ATYPICAL FEMUR FRACTURE 2
967 BACTERIAL SEPSIS 2
968 BASAL CELL CARCINOMA 2
969 BIOPSY BONE MARROW 2
970 BLADDER DISORDER 2
971 BLINDNESS TRANSIENT 2
972 BLOOD CREATININE DECREASED 2
973 BLOOD IMMUNOGLOBULIN G INCREASED 2
974 BLOOD LOSS ANAEMIA 2
975 BLOOD PH DECREASED 2
976 BLOOD PRESSURE IMMEASURABLE 2
977 BONE DENSITY DECREASED 2
978 BONE MARROW FAILURE 2
979 BOWEL MOVEMENT IRREGULARITY 2
980 BRACHYCEPHALY 2
981 BRAIN INJURY 2
982 BRAIN OPERATION 2
983 BRONCHIOLITIS 2
984 BUNDLE BRANCH BLOCK LEFT 2
985 BURSITIS 2
986 C-REACTIVE PROTEIN ABNORMAL 2
987 CARDIAC FAILURE CHRONIC 2
988 CARDIOMEGALY 2
989 CARDIOMYOPATHY 2
990 CARPAL TUNNEL SYNDROME 2
991 CENTRAL VISION LOSS 2
992 CEREBELLAR INFARCTION 2
993 CERUMEN IMPACTION 2
994 CERVICOBRACHIAL SYNDROME 2
995 CHEMICAL BURNS OF EYE 2
996 CHOLANGITIS ACUTE 2
997 CHOLANGITIS SCLEROSING 2
998 CHYLOTHORAX 2
999 CLOSTRIDIUM DIFFICILE COLITIS 2